NO965449L - Fjern-infrarödt bestrålingsmateriale og medisin og mat som fremkommer fra dette - Google Patents

Fjern-infrarödt bestrålingsmateriale og medisin og mat som fremkommer fra dette

Info

Publication number: NO965449L
Authority: NO; Norway
Prior art keywords: sges; approx; far; medicine; infrared radiation
Prior art date: 1995-12-25

Application number

NO965449A

Other languages

English (en)

Norwegian (no)

Other versions

NO965449D0 (no

Inventor

Kozo Niwa

Kazuyuki Torii

Original Assignee

Kozo Niwa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-25

Filing date

1996-12-18

Publication date

1997-06-26

1996-12-18 Application filed by Kozo Niwa filed Critical Kozo Niwa

1996-12-18 Publication of NO965449D0 publication Critical patent/NO965449D0/no

1997-06-26 Publication of NO965449L publication Critical patent/NO965449L/no

Links

239000003814 drug Substances 0.000 title claims description 11
235000013305 food Nutrition 0.000 title claims description 6
230000005855 radiation Effects 0.000 title description 24
239000004575 stone Substances 0.000 claims description 31
239000000843 powder Substances 0.000 claims description 22
239000000463 material Substances 0.000 claims description 17
239000004576 sand Substances 0.000 claims description 12
238000010298 pulverizing process Methods 0.000 claims description 10
238000000227 grinding Methods 0.000 claims description 4
229910052742 iron Inorganic materials 0.000 claims description 4
229940079593 drug Drugs 0.000 claims 4
239000011435 rock Substances 0.000 claims 3
239000000919 ceramic Substances 0.000 description 32
210000004027 cell Anatomy 0.000 description 29
210000000440 neutrophil Anatomy 0.000 description 18
230000000694 effects Effects 0.000 description 17
-1 lipid peroxide Chemical class 0.000 description 16
206010028980 Neoplasm Diseases 0.000 description 13
238000002474 experimental method Methods 0.000 description 13
201000011510 cancer Diseases 0.000 description 12
239000000203 mixture Substances 0.000 description 9
238000004519 manufacturing process Methods 0.000 description 8
230000035755 proliferation Effects 0.000 description 8
210000004369 blood Anatomy 0.000 description 7
239000008280 blood Substances 0.000 description 7
208000032839 leukemia Diseases 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 6
MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 6
210000004698 lymphocyte Anatomy 0.000 description 6
229910052613 tourmaline Inorganic materials 0.000 description 6
229940070527 tourmaline Drugs 0.000 description 6
239000011032 tourmaline Substances 0.000 description 6
241000699670 Mus sp. Species 0.000 description 5
241000700159 Rattus Species 0.000 description 5
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
239000010438 granite Substances 0.000 description 5
239000001301 oxygen Substances 0.000 description 5
229910052760 oxygen Inorganic materials 0.000 description 5
210000004881 tumor cell Anatomy 0.000 description 5
108010047620 Phytohemagglutinins Proteins 0.000 description 4
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 4
201000010099 disease Diseases 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
230000001885 phytohemagglutinin Effects 0.000 description 4
230000009467 reduction Effects 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
229920001817 Agar Polymers 0.000 description 3
108030000917 Glutamine-pyruvate transaminases Proteins 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
239000005662 Paraffin oil Substances 0.000 description 3
239000008272 agar Substances 0.000 description 3
230000000052 comparative effect Effects 0.000 description 3
235000020669 docosahexaenoic acid Nutrition 0.000 description 3
229940090949 docosahexaenoic acid Drugs 0.000 description 3
239000007789 gas Substances 0.000 description 3
230000036541 health Effects 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
210000000265 leukocyte Anatomy 0.000 description 3
238000005259 measurement Methods 0.000 description 3
230000005012 migration Effects 0.000 description 3
238000013508 migration Methods 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
238000012360 testing method Methods 0.000 description 3
208000006820 Arthralgia Diseases 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
108010075031 Cytochromes c Proteins 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
PRQROPMIIGLWRP-UHFFFAOYSA-N N-formyl-methionyl-leucyl-phenylalanin Chemical compound CSCCC(NC=O)C(=O)NC(CC(C)C)C(=O)NC(C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-UHFFFAOYSA-N 0.000 description 2
208000003782 Raynaud disease Diseases 0.000 description 2
208000012322 Raynaud phenomenon Diseases 0.000 description 2
208000006268 Sarcoma 180 Diseases 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
201000009594 Systemic Scleroderma Diseases 0.000 description 2
206010042953 Systemic sclerosis Diseases 0.000 description 2
206010043540 Thromboangiitis obliterans Diseases 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
230000004913 activation Effects 0.000 description 2
210000001142 back Anatomy 0.000 description 2
230000035584 blastogenesis Effects 0.000 description 2
244000309466 calf Species 0.000 description 2
230000008859 change Effects 0.000 description 2
230000006870 function Effects 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
229910052753 mercury Inorganic materials 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
238000000034 method Methods 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
230000000750 progressive effect Effects 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
206010039073 rheumatoid arthritis Diseases 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
201000005060 thrombophlebitis Diseases 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
206010012438 Dermatitis atopic Diseases 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
208000001382 Experimental Melanoma Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
208000008763 Mercury poisoning Diseases 0.000 description 1
206010027439 Metal poisoning Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
229930192392 Mitomycin Natural products 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
206010033799 Paralysis Diseases 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
241000700157 Rattus norvegicus Species 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
108090000340 Transaminases Proteins 0.000 description 1
102000003929 Transaminases Human genes 0.000 description 1
229920000392 Zymosan Polymers 0.000 description 1
239000002269 analeptic agent Substances 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
201000008937 atopic dermatitis Diseases 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
229910052793 cadmium Inorganic materials 0.000 description 1
BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
230000003915 cell function Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000010411 cooking Methods 0.000 description 1
230000009849 deactivation Effects 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
230000005284 excitation Effects 0.000 description 1
239000004744 fabric Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
235000013402 health food Nutrition 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
DZNKOAWEHDKBEP-UHFFFAOYSA-N methyl 2-[6-[bis(2-methoxy-2-oxoethyl)amino]-5-[2-[2-[bis(2-methoxy-2-oxoethyl)amino]-5-methylphenoxy]ethoxy]-1-benzofuran-2-yl]-1,3-oxazole-5-carboxylate Chemical compound COC(=O)CN(CC(=O)OC)C1=CC=C(C)C=C1OCCOC(C(=C1)N(CC(=O)OC)CC(=O)OC)=CC2=C1OC(C=1OC(=CN=1)C(=O)OC)=C2 DZNKOAWEHDKBEP-UHFFFAOYSA-N 0.000 description 1
230000001617 migratory effect Effects 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
235000014214 soft drink Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
235000021122 unsaturated fatty acids Nutrition 0.000 description 1
150000004670 unsaturated fatty acids Chemical class 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H33/00—Bathing devices for special therapeutic or hygienic purposes
- A61H33/04—Appliances for sand, mud, wax or foam baths; Appliances for metal baths, e.g. using metal salt solutions
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/29—Mineral substances, e.g. mineral oils or clays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H33/00—Bathing devices for special therapeutic or hygienic purposes
- A61H33/04—Appliances for sand, mud, wax or foam baths; Appliances for metal baths, e.g. using metal salt solutions
- A61H2033/041—Baths with dry sand or other dry particles

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Mycology (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Alternative & Traditional Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dispersion Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Toxicology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Rehabilitation Therapy (AREA)
Oncology (AREA)
Cardiology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Radiation-Therapy Devices (AREA)
Compositions Of Oxide Ceramics (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

NO965449A 1995-12-25 1996-12-18 Fjern-infrarödt bestrålingsmateriale og medisin og mat som fremkommer fra dette NO965449L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP7337559A JPH09173479A (ja)	1995-12-25	1995-12-25	遠赤外線放射体およびそれを用いた医薬品ならびに食品

Publications (2)

Publication Number	Publication Date
NO965449D0 NO965449D0 (no)	1996-12-18
NO965449L true NO965449L (no)	1997-06-26

Family

ID=18309788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO965449A NO965449L (no)	1995-12-25	1996-12-18	Fjern-infrarödt bestrålingsmateriale og medisin og mat som fremkommer fra dette

Country Status (18)

Country	Link
US (1)	US6004588A (it)
JP (1)	JPH09173479A (it)
KR (1)	KR970042407A (it)
CN (1)	CN1157178A (it)
AU (1)	AU727635B2 (it)
BE (1)	BE1010468A5 (it)
CA (1)	CA2193587A1 (it)
CH (1)	CH691025A5 (it)
DE (1)	DE19654232A1 (it)
DK (1)	DK143596A (it)
ES (1)	ES2124669B1 (it)
FR (1)	FR2742739B1 (it)
GB (1)	GB2308591B (it)
IS (1)	IS4400A (it)
IT (1)	IT1304596B1 (it)
NL (1)	NL1004878C2 (it)
NO (1)	NO965449L (it)
SE (1)	SE508589C2 (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100471359B1 (ko) *	2000-12-28	2005-03-07	주식회사 태평양	결정성 무기광물을 함유한 피부 외용제 조성물
US6585896B2 (en) *	2001-03-09	2003-07-01	Leon M. Silverstone	Methods and apparatus for molecular induction technology to create changes in the energetic characteristics of various materials, and their use in the production of molecular changes in other media
JP2003062093A (ja) *	2001-08-23	2003-03-04	Koichi Imai	粉状遠赤外線放射体及びその製造方法
CA2382364C (en) *	2002-01-21	2004-12-07	Sang-Ho Son	Far-infrared ray radiator and method for manufacturing the same
JP2004107549A (ja) *	2002-09-20	2004-04-08	Toshiyuki Waratani	接着剤
US20050171584A1 (en) *	2004-02-02	2005-08-04	Slingo Fred M.	Heating devices and apparatuses employing far infrared radiation and negative ions
US20050278006A1 (en) *	2004-06-10	2005-12-15	Yoshiaki Omura	Solar energy stored papers and their clinical applications
US20060229691A1 (en) *	2005-04-08	2006-10-12	Noskov Alexander G	System and method of applying a therapeutic treatment
JP2007195759A (ja) *	2006-01-26	2007-08-09	Kikuji Yamashita	癌を予防あるいは治療する住空間
US20090171423A1 (en) *	2006-03-17	2009-07-02	Fukuma Wada	Head Orthosis
WO2012156805A1 (fr) *	2011-05-18	2012-11-22	Rhodia Poliamida E Especialidades Ltda	Fils, fibres ou filaments comprenant des charges minerales; article textile dispositif medical obtenus a partir desdits fils pour la cicatrisation de la peau
CN103920574B (zh) *	2013-01-11	2017-04-26	张仁鸿	使具有人体远红外线波段的材料微细化的方法
CN103919802B (zh) *	2013-01-11	2016-09-07	张仁鸿	心血管疾病防治及生物技术保养保健材料
KR20140105640A (ko) *	2013-02-22	2014-09-02	(주)엘지하우시스	복사열을 이용한 자동차용 면상 발열체
WO2017212299A2 (en) *	2016-06-07	2017-12-14	Kunfalvi Gábor	Artificially produced, intense infrared radiation emitting ceramic composites
CN108816447B (zh) *	2018-06-15	2020-04-21	温州医科大学	一种基于分层收集的中药粉碎机及其中药粉碎方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3724125A1 (de) *	1987-07-21	1989-02-02	Bavaria Cargo Tech	Rollenfoerderbahn
JPH01289423A (ja) *	1988-05-17	1989-11-21	Tomoaki Otsuka	植物生長法
CA1326442C (en) *	1988-06-15	1994-01-25	Setsumi Tanase	Sheet material for skin contact medical treatment
JPH0262812A (ja) *	1988-08-29	1990-03-02	Kanebo Ltd	皮膚化粧料
JPH03112849A (ja) *	1989-09-25	1991-05-14	Nariyuki Furuta	遠赤外線放射性粉末、及びその焼結物の製造方法とその使用方法。
CN1094992A (zh) *	1993-05-10	1994-11-16	吴建	稀土远红外功能陶瓷球体的成型工艺
JPH0859488A (ja) *	1994-08-12	1996-03-05	Masatoshi Nakano	健康増進剤
JPH08175863A (ja) *	1994-12-22	1996-07-09	Fuji Giken Kk	焼結組成物及び混合物
US5802846A (en) *	1997-03-31	1998-09-08	Caterpillar Inc.	Exhaust gas recirculation system for an internal combustion engine
JPH10289423A (ja) *	1997-04-10	1998-10-27	Minebea Co Ltd	垂直磁気記録用複合型ヘッドの製造方法

1995
- 1995-12-25 JP JP7337559A patent/JPH09173479A/ja active Pending
1996
- 1996-12-17 DK DK143596A patent/DK143596A/da not_active Application Discontinuation
- 1996-12-18 NO NO965449A patent/NO965449L/no not_active Application Discontinuation
- 1996-12-19 AU AU75480/96A patent/AU727635B2/en not_active Ceased
- 1996-12-19 IS IS4400A patent/IS4400A/is unknown
- 1996-12-19 GB GB9626379A patent/GB2308591B/en not_active Expired - Fee Related
- 1996-12-20 SE SE9604709A patent/SE508589C2/sv not_active IP Right Cessation
- 1996-12-20 IT IT1996TO001061A patent/IT1304596B1/it active
- 1996-12-20 US US08/770,254 patent/US6004588A/en not_active Expired - Lifetime
- 1996-12-20 CA CA002193587A patent/CA2193587A1/en not_active Abandoned
- 1996-12-23 KR KR1019960070210A patent/KR970042407A/ko not_active Ceased
- 1996-12-23 CH CH03169/96A patent/CH691025A5/fr not_active IP Right Cessation
- 1996-12-23 FR FR9615856A patent/FR2742739B1/fr not_active Expired - Fee Related
- 1996-12-23 NL NL1004878A patent/NL1004878C2/nl not_active IP Right Cessation
- 1996-12-23 DE DE19654232A patent/DE19654232A1/de not_active Withdrawn
- 1996-12-24 CN CN96123810A patent/CN1157178A/zh active Pending
- 1996-12-24 ES ES009602728A patent/ES2124669B1/es not_active Expired - Fee Related
- 1996-12-24 BE BE9601080A patent/BE1010468A5/fr not_active IP Right Cessation

Also Published As

Publication number	Publication date
SE9604709L (sv)	1997-06-26
IT1304596B1 (it)	2001-03-19
GB2308591B (en)	2000-01-19
IS4400A (is)	1997-06-26
CA2193587A1 (en)	1997-06-26
ITTO961061A1 (it)	1998-06-20
CH691025A5 (fr)	2001-04-12
CN1157178A (zh)	1997-08-20
JPH09173479A (ja)	1997-07-08
GB2308591A (en)	1997-07-02
NL1004878C2 (nl)	1998-03-06
DE19654232A1 (de)	1997-06-26
SE9604709D0 (sv)	1996-12-20
GB9626379D0 (en)	1997-02-05
SE508589C3 (it)	1998-11-09
BE1010468A5 (fr)	1998-09-01
DK143596A (da)	1997-06-26
NL1004878A1 (nl)	1997-07-02
KR970042407A (ko)	1997-07-24
AU7548096A (en)	1997-07-03
FR2742739A1 (fr)	1997-06-27
NO965449D0 (no)	1996-12-18
ES2124669A1 (es)	1999-02-01
FR2742739B1 (fr)	1998-09-25
AU727635B2 (en)	2000-12-14
US6004588A (en)	1999-12-21
ES2124669B1 (es)	1999-11-16
SE508589C2 (sv)	1998-10-19

Legal Events

Date	Code	Title	Description
2002-09-16	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO965449L (no)	1997-06-26	Fjern-infrarödt bestrålingsmateriale og medisin og mat som fremkommer fra dette
De Gruijl	1997	Health effects from solar UV radiation
Chaturvedi et al.	2004	Viral infections and trace elements: a complex interaction
Schempp et al.	2000	Magnesium ions inhibit the antigen-presenting function of human epidermal Langerhans cells in vivo and in vitro. Involvement of ATPase, HLA-DR, B7 molecules, and cytokines
Sperduto et al.	1990	Do we have a nutritional treatment for age-related cataract or macular degeneration?
KR101870846B1 (ko)	2018-06-25	다기능성 조성물 및 이의 제조 방법과 용도
Nowosielska et al.	2006	Enhanced cytotoxic activity of macrophages and suppressed tumor metastases in mice irradiated with low doses of X-rays
NL194359C (nl)	2002-02-04	Werkwijze voor het bereiden van een plantaardige samenstelling met ontstekingsremmende werking.
CN109453188A (zh)	2019-03-12	一种沙虫多糖在制备防治骨质疏松药物或保健品中的应用
Cestari et al.	1995	Ultraviolet radiation decreases the granulomatous response to lepromin in humans
Applegate et al.	1991	DNA damage is involved in the induction of opacification and neovascularization of the cornea by ultraviolet radiation
Gonzalez	1995	PUVA for psoriasis
KR20000054996A (ko)	2000-09-05	연옥분이 함유된 화장료와 그 제조방법
Granstein et al.	1983	The role of suppressor cells in the induction of murine photoallergic contact dermatitis and in its suppression by prior UVB irradiation.
CN104759035B (zh)	2017-07-18	一种利用兹阳石制做保健用品的方法
Norval	2002	Immunosuppression induced by ultraviolet radiation: relevance to public health
Baruchin	1994	Erythema abigne-a neglected entity?
Ogundigie et al.	1995	Effect of biochanin-a or testosterone on liver-tumors induced by a combined treatment of den and fission neutron in bcf1 mice
JPH0859488A (ja)	1996-03-05	健康増進剤
Thomson	1971	Onchocerciasis in an oil palm estate
Diah et al.	2023	Periodontists' and Orthodontists' Challenge in Periodontal Health: Role of Vitamin D3 Deficiency?
KR0129551B1 (ko)	1998-04-09	연옥분이 함유된 피부 첩부제(貼付劑)
Seong et al.	1990	A case of Molluscum Contagiosum treated with Diphenylcyclopropenone immunotherapy
JP2589662B2 (ja)	1997-03-12	鉱物粉混合健康増進材及び健康増進具
KR102339100B1 (ko)	2021-12-16	염증 완화 또는 개선용 세라믹 조성물(ndc) 및 이의 제조방법